Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by nemo3on Jan 05, 2019 2:13pm

88 Views

Post# 29190325

RE:RE:RE:AbbVie to Record $4 Billion Impairment on Stemcentrx Assets

I don't disagree with you chry in that TLT has shown some fantastic results. But the number of patients treated was only 6. Larger numbers in Ph2 will help determine if the success first achieved carries over into larger numbers of patients treated. I certainly hope it does but I have seen before where initial success in smaller numbers became less of a success in larger numbers.

Yes, patience is needed and I am willing to wait it out.

Bullboard Posts

Unique Battery Metals opportunity in Quebec